A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
Condition(s):Brain TumorsLast Updated:June 12, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Brain TumorsLast Updated:June 12, 2023Completed
Condition(s):CNS Tumor, AdultLast Updated:April 20, 2016Completed
Condition(s):Glioma; Malignant Glioma; Astrocytoma, Grade II; Oligodendroglioma; Glioma, Astrocytic; Oligoastrocytoma, MixedLast Updated:March 27, 2023Active, not recruiting
Condition(s):Low-Grade B-cell LymphomaLast Updated:September 22, 2022Completed
Condition(s):Stage IV NSCLCLast Updated:February 13, 2024Not yet recruiting
Condition(s):MelanomaLast Updated:October 2, 2015Terminated
Condition(s):Cancer of Ovary; Neoplasms, Ovarian; Ovarian Cancer Stage IV; Ovarian Cancer Recurrent; Ovarian Cancer Stage III; Ovary CancerLast Updated:December 22, 2020Terminated
Condition(s):B Cell Lymphoma; T Cell LymphomaLast Updated:July 20, 2011Terminated
Condition(s):Healthy VolunteersLast Updated:March 28, 2014Completed
Condition(s):Non-Hodgkin’s Lymphoma; Metastatic Breast Cancer; Head and Neck Squamous Cell CarcinomaLast Updated:January 30, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.